At 6.0% CAGR, the South & Central America Cardiac Microcatheter Market is projected to be worth US$ 30.42 million by 2028, says Business Market Insights

According to Business Market Insights research, the South & Central America cardiac microcatheter market was valued at US$ 22.69 million in 2023 and is expected to reach US$ 30.42 million by 2028, registering a CAGR of 6.0% from 2023 to 2028. High prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO) are the critical factors attributed to the South & Central America cardiac microcatheter market expansion.        

As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in complex vascular anatomies. Manufacturers across the region are investing in research and development of advanced technologies, which has led to the development of new and advanced products, along with a surge in product approvals. A few product approvals and developments are listed as In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions. In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease. Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheter is expected to fuel the cardiac microcatheter market growth during the forecast period.

On the contrary, complications and failures related to usage of cardiac microcatheters hampers the South & Central America Cardiac Microcatheter Market.  

Based on indication, the South & Central America cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held 58.0% share of South & Central America Cardiac Microcatheter Market in 2023, amassing US$ 13.15 million. It is projected to garner US$ 17.78 million by 2028 to expand at 6.2% CAGR during 2023–2028.

Based on end user, the South & Central America cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held 45.8% share of South & Central America Cardiac Microcatheter Market in 2023, amassing US$  10.38 million. It is projected to garner US$ 14.14 million by 2028 to expand at 6.4% CAGR during 2023–2028.

Based on country, the South & Central America cardiac microcatheter market  has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 59.0% share of South & Central America Cardiac Microcatheter Market in 2023. It was assessed at US$ 13.38 million in 2023 and is likely to hit US$ 18.29 million by 2028, exhibiting a CAGR of 6.4% during the forecast period.      

Key players dominating the South & Central America cardiac microcatheter market are Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; and Teleflex Inc, among others.   

• In July 2021, Terumo Medical Corporation (TMC) announced AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the blood flow rate in peripheral vasculature arteries.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com